RxDoctor Payments Data

Alix Charles, DPM

Foot Surgery · Plantation, FLNPI 1023114600

Payments from drug & device makers

What this record shows

19 manufacturers reported payments, led by Musculoskeletal Transplant Foundation Inc. at 35.5% of the total. Reporting peaked in 2021 at $1,988 and has fallen 64.7% since, to $702 in 2025. Among foot surgery clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,830in general payments, 2019–2025

Across 73 payments — averaging $107.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Musculoskeletal Transplant Foundation Inc.$3K
  • Biotissue Holdings Inc.$2K
  • Endo Pharmaceuticals Inc.$939
  • Paratek Pharmaceuticals, Inc.$515
  • Kerecis Limited$409
  • Amgen$280
  • plus $1K from 13 others

What the payments were for

  • Travel & lodging$3,56145%
  • Food & beverage$4,26955%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,830 in reported general payments places this provider in the 90th percentile of 107 foot surgery providers in Florida.

See all foot surgery providers in Florida

Medicare billing

Part B allowed, 2024
$51,116
Medicare patients
169
Services billed
530

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clotrimazole201$8,045
Pentoxifylline88$3,831
Ammonium Lactate172$3,129
Ciclopirox87$1,885
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip72$1,467
Diclofenac Sodium26$890
Gabapentin124$873
Ketoconazole38$747
Pregabalin17$268
Ciprofloxacin Hcl13$163
Indomethacin15$139
Cephalexin22$123
Ibuprofen24$68

Paid to pharmacies, not to this prescriber.

Other foot surgery in Plantation

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →